Role of peroxisome proliferators-activated receptors in the pathogenesis and treatment of nonalcoholic fatty liver disease

World Journal of Gastroenterology

Volumn 14, Issue 1, 2008, Pages 22-28

  Kallwitz, Eric R ^a,c   McLachlan, Alan ^b   Cotler, Scott J ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c NONE   (United States)

Author keywords

Insulin resistance; Metabolic syndrome; Non alcoholic fatty liver disease; Peroxisome proliferators activated receptors; Pharmacologic ligands

Indexed keywords

ADIPONECTIN; ALPHA TOCOPHEROL; BEZAFIBRATE; FENOFIBRATE; FIBRIC ACID DERIVATIVE; GEMFIBROZIL; GLITAZONE DERIVATIVE; LIGAND; OMEGA 3 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; PLACEBO; ROSIGLITAZONE; TRIACYLGLYCEROL;

ADIPOGENESIS; ALANINE AMINOTRANSFERASE BLOOD LEVEL; CELL DIFFERENTIATION; COMBINATION CHEMOTHERAPY; DIET SUPPLEMENTATION; DIET THERAPY; DRUG MECHANISM; EXERCISE; FATTY ACID OXIDATION; FATTY LIVER; GLYCEMIC CONTROL; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID STORAGE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; RECEPTOR BINDING; REVIEW;

EID: 39849099238     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.22     Document Type: Review

References (108)